UPXI Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 -50.99%, SMA50 -61.88%, SMA200 -86.85%). The stock’s 14-day RSI is 21.71 (weak momentum), while the ATR of 0.17 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -96.81% below its high and over 0.98% above its low. Average 10-day trading volume of 5.06 million shares is slightly above the 3-month average of 4.19 million, indicating heightened recent market interest.

Upexi, Inc. (NASDAQ:UPXI) closed at $0.69 USD, losing -$0.03 (-4.17%) from the previous close of $0.72. The stock is currently trading near its 52-week low $0.69 and $22.57. With a market capitalization of about $47.85 million, Upexi, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.46). Key stats such as the average daily volume over the past year has been around 4.23 million shares, in line with its 52-week average. Headquartered in Clearwater, FL, Upexi, Inc. operates in the Communication Services sector and the Internet Content & Information industry. Led by CEO Allan J. Marshall, the company employs approximately 64 people and listed since June 24, 2021. Upexi, Inc. manufacture and sells various branded products in the health, wellness, pet, beauty, and other markets.

Upexi, Inc. has 58.89 million shares outstanding. The public float is 32.68 million shares, elevated short interest at 9.41% of float. This equals 5.42 million shares. The short ratio is 0.69 days. Institutional investors hold 31.02% of the float. Insiders own 20.34%. MARSHALL ALLAN holds 4.05 million shares, Salkind Gene has 218.75 thousand shares and Dugan Lawrence has 116.39 thousand shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Upexi, Inc. generated EPS of -$5.24 over the past year. Five-year average earnings growth is 25.24%. The latest quarter delivered EPS of -$0.12. The next quarter is forecast at -$0.10. Next year's EPS is expected at $139.13. Analyst sentiment is bullish. Analyst rating data shows there are 2 Strong Buy ratings, 0 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $6.00 to $6.00. The high target offers 769.57% upside. The low target suggests 769.57% downside. The mean target is $6.00. This offers 769.57% upside. Upexi, Inc. earnings surprise history is a mixed track record. The quarter that ended November 11, 2025, missed forecasts by 1100.0%. The prior quarter beat by 600.0%. Over the last six quarters, Apple has recorded several small beats. These include -13.89% in December 19, 2024.

Upexi, Inc. (NASDAQ:UPXI) shares are up 20.83% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Upexi, Inc. trading at a premium to the broader market with a P/E of -0.34. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $6.43, suggesting 831.88% upside. Our AI forecast model points to short-term weakness (-55.07% over two weeks), a medium-term rise (30.43% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Upexi, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -55.07%, with price expected at $0.31 by March 04, 2026, within a range of $0.00 to $0.68 3-Month Outlook: Projected rise of 30.43%, reaching $0.90 by May 18, 2026, with a range of $0.43 to $1.29. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by February 18, 2027, within a range of $0.00 to $0.80.

Upexi, Inc. trades at a P/E ratio of -0.34, slightly below the S&P 500 average, with a price-to-sales ratio of 1.94 and a price-to-book ratio of 0.86 suggesting the stock is closer to book value. The P/FCF stands at -2.7, also below market averages.